[EXPERIENCES IN THE USE OF AVAFORTAN, A SPASMO-ANALGESIC AGENT].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D000983:Antipyrine; D001657:Biliary Dyskinesia; D002764:Cholecystitis; D002769:Cholelithiasis; D004177:Dipyrone; D004338:Drug Combinations; D004358:Drug Therapy; D004381:Duodenal Ulcer; D005998:Glycine / Q000031:analogs & derivatives; D006689:Hodgkin Disease; D006801:Humans; D007669:Kidney Calculi; D009125:Muscle Relaxants, Central; D010648:Phenylacetates; D011720:Pyrazoles
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D004338:Drug Combinations; D009125:Muscle Relaxants, Central; D010648:Phenylacetates; D011720:Pyrazoles; C038564:camylofin, dipyrone drug combination; D004177:Dipyrone; D000983:Antipyrine; D005998:Glycine
ANALGESICS AND ANTIPYRETICS; ANTIPYRINE; BILIARY DYSKINESIA; CHOLECYSTITIS; CHOLELITHIASIS; DRUG THERAPY; DUODENAL ULCER; HODGKIN'S DISEASE; KIDNEY CALCULI; MUSCLE RELAXANTS; PYRAZOLES
ERHAUGEN MIT DEM SPASMOANALGETIKUM AVAFORTAN.